UY26618A1 - PHARMACEUTICAL COMPOSITIONS OF INHIBITORS OF THE G PHARMACEUTICAL COMPOSITIONS OF GLYCOGEN-PHOSPHORILASE INHIBITORS - Google Patents

PHARMACEUTICAL COMPOSITIONS OF INHIBITORS OF THE G PHARMACEUTICAL COMPOSITIONS OF GLYCOGEN-PHOSPHORILASE INHIBITORS

Info

Publication number
UY26618A1
UY26618A1 UY26618A UY26618A UY26618A1 UY 26618 A1 UY26618 A1 UY 26618A1 UY 26618 A UY26618 A UY 26618A UY 26618 A UY26618 A UY 26618A UY 26618 A1 UY26618 A1 UY 26618A1
Authority
UY
Uruguay
Prior art keywords
pharmaceutical compositions
inhibitors
glycogen
phosphorilase
polymer
Prior art date
Application number
UY26618A
Other languages
Spanish (es)
Inventor
Ravi Mysore Shanker
Dennis Jay Hoover
Dwayne Thomas Friesen
Douglas Alan Lorenz
James Alan Schrive Nightingale
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Priority to UY26618A priority Critical patent/UY26618A1/en
Publication of UY26618A1 publication Critical patent/UY26618A1/en

Links

Abstract

Composiciones farmacéuticas que contienen un inhibidor de la glucógeno-fosforilasa y como mínimo un polímero que aumenta la concentración. La composición puede ser una mezcla física simple de un inhibidor de la gluocógenao-fosforilasa y un polímero que aumenta la concentración, o una dispersión de un inhibidor de la glucógeno-fosforilasa y un polímero.Pharmaceutical compositions containing a glycogen phosphorylase inhibitor and at least one polymer that increases concentration. The composition can be a simple physical mixture of a glycogen phosphorylase inhibitor and a concentration-increasing polymer, or a dispersion of a glycogen phosphorylase inhibitor and a polymer.

UY26618A 2001-03-15 2001-03-15 PHARMACEUTICAL COMPOSITIONS OF INHIBITORS OF THE G PHARMACEUTICAL COMPOSITIONS OF GLYCOGEN-PHOSPHORILASE INHIBITORS UY26618A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
UY26618A UY26618A1 (en) 2001-03-15 2001-03-15 PHARMACEUTICAL COMPOSITIONS OF INHIBITORS OF THE G PHARMACEUTICAL COMPOSITIONS OF GLYCOGEN-PHOSPHORILASE INHIBITORS

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
UY26618A UY26618A1 (en) 2001-03-15 2001-03-15 PHARMACEUTICAL COMPOSITIONS OF INHIBITORS OF THE G PHARMACEUTICAL COMPOSITIONS OF GLYCOGEN-PHOSPHORILASE INHIBITORS

Publications (1)

Publication Number Publication Date
UY26618A1 true UY26618A1 (en) 2001-10-25

Family

ID=38812366

Family Applications (1)

Application Number Title Priority Date Filing Date
UY26618A UY26618A1 (en) 2001-03-15 2001-03-15 PHARMACEUTICAL COMPOSITIONS OF INHIBITORS OF THE G PHARMACEUTICAL COMPOSITIONS OF GLYCOGEN-PHOSPHORILASE INHIBITORS

Country Status (1)

Country Link
UY (1) UY26618A1 (en)

Similar Documents

Publication Publication Date Title
AR027656A1 (en) PHARMACEUTICAL COMPOSITIONS OF INHIBITORS OF GLUCOGENO-FOSFORILASA
PA8564901A1 (en) PHARMACEUTICAL COMPOSITIONS OF INHIBITORS OF THE CHOLESTERILE ESTERES TRANSFER PROTEIN
SE0102315D0 (en) Compounds
DK1515702T6 (en) ABUSE PROTECTED SUBMISSION FORM
BR0207296B1 (en) coating composition.
HK1074592A1 (en) 17 beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
UA88463C2 (en) Pharmaceutical composition comprising compound i and method of treating hiv infection
CR6883A (en) PHARMACEUTICAL COMPOSITIONS OF INHIBITORS OF THE POWER OF CHOLESTERIL ESTER
DE60007095T2 (en) CALANOLIDE FOR INHIBITING BTK
AR038207A1 (en) ORIGINALLY DISPERSABLE PHARMACEUTICAL COMPOSITION OF AGOMELATINE
PT1117440E (en) PHARMACEUTICAL COMPOSITIONS CONTAINING PACLITAXEL
TW200738817A (en) Blends of biopolymers with acrylic copolymers
NO20052312L (en) Combination product of inhibitor from the SRC family of non-receptor tyrosine kinases and gemcitabine.
ECSP109852A (en) USE OF HOMO AND COPOLYMERS FOR THE STABILIZATION OF FORMULATIONS OF ACTIVE PRINCIPLES
MX2007005408A (en) Aminoquinazolines compounds.
BR0208142A (en) Combinations comprising an antidiarrheal agent and epothilone or epothilone derivative
BRPI0515721A (en) use of a src kinase inhibitor and a bcr-abl inhibitor, pharmaceutical composition and combination
ATE496109T1 (en) REACTION PRODUCTS OF MERCAPTOBENZOTHIAZOLES, MERCAPTOTHIAZOLINES AND MERCAPTOBENZIMIDAZOLES WITH EPOXIES AS LUBRICANT ADDITIVES
MXPA03010158A (en) Sulfonamides.
MY130792A (en) 17ß-HYDROXYSTEROID DEHYDROGENASE TYPE 3 INHIBITORS FOR THE TREATMENT OF ANDROGEN DEPENDENT DISEASES
RS51534B (en) NEW ASSOCIATION OF AN If SINUSOIDAL CURRENT INHIBITOR AND A CALCIUM CHANNEL-BLOCKING AGENT, AND PHARMACEUTICAL INGREDIENTS CONTAINING SAID ASSOCIATION
MXPA03001455A (en) Pyrazole compounds, pharmaceutical compositions, and methods for modulating or inhibiting erab or hadh2 activity.
ATE354291T1 (en) COMPOSITIONS CONTAINING AT LEAST PUMPKIN OIL AND BORRAGE OIL, THEIR USE AS A MEDICINAL PRODUCT, DERMATIC OR DERMATOCOSMETIC COMPOSITION
ATE410154T1 (en) PHARMACEUTICAL COMPOSITION CONTAINING 2,4-DICHLOROBENZYL ALCOHOL AND AMYLMETACRESOL
UY26618A1 (en) PHARMACEUTICAL COMPOSITIONS OF INHIBITORS OF THE G PHARMACEUTICAL COMPOSITIONS OF GLYCOGEN-PHOSPHORILASE INHIBITORS

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20130626